Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Interest & Investment Income (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Interest & Investment Income for 12 consecutive years, with $865000.0 as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income rose 101.63% to $865000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, up 19.49% year-over-year, with the annual reading at $1.9 million for FY2025, 19.49% up from the prior year.
  • Interest & Investment Income hit $865000.0 in Q4 2025 for vTv Therapeutics, up from $399000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $865000.0 in Q4 2025 to a low of $1000.0 in Q1 2021.
  • Historically, Interest & Investment Income has averaged $266250.0 across 5 years, with a median of $152500.0 in 2022.
  • Biggest five-year swings in Interest & Investment Income: crashed 91.67% in 2021 and later soared 387.5% in 2024.
  • Year by year, Interest & Investment Income stood at $1000.0 in 2021, then soared by 15100.0% to $152000.0 in 2022, then tumbled by 42.11% to $88000.0 in 2023, then skyrocketed by 387.5% to $429000.0 in 2024, then skyrocketed by 101.63% to $865000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for VTVT at $865000.0 in Q4 2025, $399000.0 in Q3 2025, and $275000.0 in Q2 2025.